Gemma E. Hartley - Concepedia

Author

Gemma E. Hartley

Monash University ORCID

Also Known As

Gemma E Hartley, Gemma E. Hartley

Publications

460

Citations

H-Index

Concepts

All Affiliations

Monash University Burnet Institute The University of Melbourne Peter Doherty Institute The Alfred Hospital

About

Gemma E. Hartley is an author at Monash University specializing in humoral immunity, medicine, and covid-19.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	33
2	Immunology	2	2	33
3	Cell Biology	1	1	16
4	Clinical Immunology	1	1	16
5	Autoimmunity	1	1	16

Gemma E. Hartley

Publications

423

Citations

H-Index

Page 1

	Year	Citations
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence Gemma E. Hartley, Emily S.J. Edwards, Pei M. Aui, Science Immunology	2020	325
Influenza‐specific IgG1<sup>+</sup> memory B‐cell numbers increase upon booster vaccination in healthy adults but not in patients with predominantly antibody deficiency Gemma E. Hartley, Emily S.J. Edwards, Julian J. Bosco, Clinical & Translational Immunology	2020	20
Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Biochemical Society Transactions Adaptive Immune SystemB-cell MemoryHumoral ResponseImmunologyImmune System	2022	17
COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Journal of Clinical Immunology	2023	17
Rapid and lasting generation of B-cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 disease and convalescence Gemma E. Hartley, Emily S.J. Edwards, Pei M. Aui, Clinical ImmunologyAdaptive Immune SystemB-cell MemoryImmunodeficienciesCellular Immunology	2020	16
Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, npj Vaccines	2024	15
Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2 Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Frontiers in Immunology	2022	13

Page 1